Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

HSV PepMix Pools: Antigen-Spanning Peptides for HSV Proteins

Respiratory Syncytial Virus (RSV) About RSV Respiratory Syncytial Virus (RSV) is a negative-sense single-stranded RNA virus belonging to the family of pneumoviridae. The spherical envelope structure of the virus is comprised of a lipid layer and transmembrane

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Respiratory Syncytial Virus (RSV)

About RSV

Respiratory Syncytial Virus (RSV) is a negative-sense single-stranded RNA virus belonging to the family of pneumoviridae. The spherical envelope structure of the virus is comprised of a lipid layer and transmembrane surface proteins such as glycoproteins, fusion proteins, and small hydrophobic proteins. Moreover, the inner helical nucleocapsid formation is surrounded by matrix proteins, and other regulatory proteins. Human RSV distinguishes between two antigen subtypes (A and B).

RSV Transmission

RSV Infection

RSV Vaccines

JPT's RSV Peptide Tools

Filter products

B-cell Immunity

Cancer biomarker research

T-cell immunity

Antigen Peptides

PepMix Peptide Pools

PepMix Peptide Pools Infections

PepStar Peptide Microarrays

Bronchiolitis

Infection

Opportunistic infections

Respiratory infection

Sequence diversity

Respiratory Syncytial Virus (RSV)

Fusion glycoprotein F0

Glycoprotein

Major surface glycoprotein G

Matrix proteins

Nucleoprotein

Selected proteins

No

Human RSV A (strain A2) Fusion glycoprotein F0 141-155, LLGVGSAIASGVAVS

US$178.10

Human RSV A (strain A2) Fusion glycoprotein F0 201-215, KQLLPIVNKQSCSIS

Human RSV A (strain A2) Fusion glycoprotein F0 21-35, CFASGQNITEEFYQS

Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV

Human RSV Fusion glycoprotein F0 299-312, VQLPLYGVIDTPCWK

US$533.00

Human RSV Fusion glycoprotein F0 321-335, LCTTNTKEGSNICLT

Human RSV Fusion glycoprotein F0 461-475, KQEGKSLYVKGEPII

Human RSV Fusion glycoprotein F0 81-95, QELDKYKNAVTELQL

Human RSV Fusion glycoprotein F0 85-93, KYKNAVTEL

Human RSV Nucleoprotein 306-314, NPKASLLSL

Cellular Immune Response

PepMix Peptide Pools

efficient for antigen-specific stimulation in T cell assays such as ELISPOT and flow cytometry

highest quality and batch-to-batch consistency

PepMix Peptide Pools for various RSV virus antigens

PepMix Pan-RSV Select: coming soon

Custom PepMix Peptide Pools tailored to your specific needs

PepTrack Peptide Libraries

T-cell assays High-throughput T-cell epitope discovery

Monitoring of cellular immune response

Monitoring of cellular response

Custom Peptide Synthesis

We are the experts for peptide synthesis with highest quality optimized for many applications. Our peptide synthesis service has a very high success rate (over 99%) as we optimize the appropriate peptide synthesis method for each peptide. If you would like to order a quality peptide synthesis using regulated processes, choose JPT!

Humoral Immune Response

Immune monitoring of humoral responses

Profiling of monkeypox-specific samples or antibodies

Evaluation of co-infection * Detection of epitopes and epitope spreading

PepStar Peptide Microarrays for various Vaccinia virus antigens: e.g. Protein L3, IMV heparin binding surface protein, cell surface-binding protein and more

Custom PepStar Peptide Micoarrays: you define content and layout

·

Peptide ELISA

In addition to high-content peptide microarrays, JPT offers the development of peptide based enzyme-linked immunosorbent assays (ELISA). This common analytical and highly sensitive immunological assay is well established for proteins but requires detailed experimental expertise for peptides.

Clinical Peptides

References

Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in highrisk transplant recipients: An Interventional Cohort StudyHall et al., Clinical Microbiology and Infection (2025) - PMID: 41016596Products used: PepMix™ HRSVA (Fusion Glycoprotein F0)

RSV Prefusion F3 Vaccine in Lung Transplant Recipients elicits CD4+ T-cell response in all VaccineesHavlin et al., American Journal of Transplantation (2025) - PMID: 40169094Product used: PepMix™ HRSVB (Fusion Glycoprotein F0)

Zelluläres und humorales Impfansprechen sowie Verträglichkeit einer Impfung gegen das humane respiratorische Synzytial-Virus (RSV) mit Arexvy bei chronischer NierenkrankheitRadun, Dissertation (2025)Products used: PepMix™ HRSVA (Fusion Glycoprotein F0), PepMix™ Pan-RSV Select, PepMix™ HRSVB (Fusion Glycoprotein F0)

Immunogenicity of RSV Fusion Protein Adsorbed to Non-Pathogenic Bacillus subtilis Spores: Implications for Mucosal Vaccine Delivery in Nonclinical Animal ModelsXiao et al., Biomedicines (2025) Product used: Custom PepMix (RSV F protein)

A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responsesBakkers et al., Nature Microbiology (2024)

Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical modelsSaeland et al., Vaccines (2023) Product used: PepMix HRSVA (Fusion Glycoprotein F0)

Humoral and Cellular Immunity to RSV in Infants, Children and AdultsGreen et al., Vaccine (2018) - PMID: 30177258

PCPP-Adjuvanted Respiratory Syncytial Virus (RSV) sF Subunit Vaccine: Self-Assembled Supramolecular Complexes Enable Enhanced Immunogenicity and Protection Cayatte et al., Molecular Pharmaceutics (2017) - PMID: 28544850

Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus Eyles et al., The Journal of Infectious Disease (2013) - PMID: 23596321

Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected PatientsCollarini et al., Journal of Immunology (2009) - PMID: 19841167

Application Notes

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →